Drug Discovery
Brigham Genomic Medicine brings together scientists and clinicians to diagnose, discover genetic underpinnings of disease, and shape treatment
Partnership combines Intellegens’ proprietary AI technology with Optibrium’s expertise in predictive modeling and compound design
Thorough method validation can be tedious, but not doing it right means wasted time, money, and resources
Scripps Research scientists have developed a powerful new strategy for synthesizing molecular skeletons of chemicals used in drugs and other important products
Fraser Glickman, PhD shares some details on the work being done in his core facility.
Validated tissue bank and pre-collected immuno-oncology datasets speed up investigative research projects through to clinical development
Novel features include modeling for drug metabolism prediction and virtual library enumeration
Collaboration combines expertise in novel chemical compound synthesis with GMP manufacture in drug discovery
PhoreMost has built a pipeline of novel targets and early drug discovery programs using its next-generation “SITESEEKER®” phenotypic screening platform
GE Healthcare Life Sciences introduces Biacore 8K+, an eight-needle high-sensitivity surface plasmon resonance (SPR) system
